Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dova Pharmaceuticals
Pharma
In $1.7B buy, Sobi acquires CTI and myelofibrosis drug Vonjo
Sobi has enhanced its hematology portfolio with a $1.7B acquisition of CTI and its potential blockbuster myelofibrosis treatment Vonjo.
Kevin Dunleavy
May 10, 2023 11:25am
Tiny Dova and its Doptelet drug take on Novartis blockbuster
Jun 28, 2019 10:25am
Salix inks deal with Dova, 3rd recent deal to boost portfolio
Oct 5, 2018 11:03am